The Financial Post reports in its Wednesday edition that Health Canada has suspended Canntrust Holdings' licences to sell cannabis and curtailed its ability to produce new plants after it was found to be growing cannabis in unlicensed rooms.
The Post's Victor Ferreira writes that Canntrust received a notice from Health Canada stating that its licences for "standard processing, medical sales, cannabis drugs and research issued under the Cannabis regulations" were being fully suspended, while its licence for standard cultivation would be under partial suspension. Canntrust will now be barred from growing new lots or batches of cannabis and from selling or distributing any products, but will still be able to "cultivate and harvest existing lots of batches" as well as trim, mill and dry that product.
Health Canada said that action was being taken "in order to protect public health and safety."
Health Canada said Canntrust may see its licences reinstated "if the reasons for the suspension no longer exist or if Canntrust demonstrates that the suspension was unfounded." Canntrust said it was reviewing the release with its counsel.
Canntrust says it "remains committed to being in full regulatory compliance."
© 2019 Canjex Publishing Ltd. All rights reserved.